WallStreetZenWallStreetZen

NASDAQ: ATHA
Athira Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ATHA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$117.7M
Current Profit Margin
0%

ATHA Return on Equity

Current Company
-69.1%
Current Industry
-63.5%
Current Market
188%
ATHA's Return on Equity (-69.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ATHA announces earnings.

ATHA Return on Assets

Current Company
-59.9%
Current Industry
2.9%
ATHA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ATHA Return on Capital Employed

Current Company
-89.55%
Current Industry
19.5%
ATHA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ATHA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ATHA$0.00-$116.49M-$117.67MN/AN/A
ALRN$0.00-$15.61M-$15.73MN/AN/A
PMVP$0.00-$68.07M-$68.96MN/AN/A
IFRX$68.58k-$45.72M-$46.38MN/AN/A
PLX$65.49M$11.65M$8.31M+13.85%N/A
View Top Biotech Stocks

ATHA earnings dates

Next earnings date
May 9, 2024

Athira Pharma Earnings & Revenue FAQ

What were ATHA's earnings last quarter?

On Invalid Date, Athira Pharma (NASDAQ: ATHA) reported Q4 2023 earnings per share (EPS) of -$0.71, up 10.13% year over year. Total Athira Pharma earnings for the quarter were -$27.29 million. In the same quarter last year, Athira Pharma's earnings per share (EPS) was -$0.79.

If you're new to stock investing, here's how to buy Athira Pharma stock.

What was ATHA's earnings growth in the past year?

As of Q2 2024, Athira Pharma's earnings has grown year over year. Athira Pharma's earnings in the past year totalled -$117.67 million.

What is ATHA's earnings date?

Athira Pharma's earnings date is Invalid Date. Add ATHA to your watchlist to be reminded of ATHA's next earnings announcement.

What was ATHA's revenue last quarter?

On Invalid Date, Athira Pharma (NASDAQ: ATHA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Athira Pharma's revenue was $0.00.

What was ATHA's revenue growth in the past year?

As of Q2 2024, Athira Pharma's revenue has grown null year over year. Athira Pharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.